QCPU was established as a cost-recovery funding model. We provide Queen’s researchers with the experience and access to cutting-edge technology to bring their research to the next level. Currently, QCPU boasts 10 SuperUsers, defined as users who purchase service in blocks of 208 (SuperUser A plan) or 104 (SuperUser B plan) hours/year. We serve 24 research groups across 10 departments, 3 faculties and 3 universities. QCPU scientists have assisted or mentored over 60 trainees, including research staff, medical students, post-doctoral fellows, graduate students and undergrads. QCPU has contributed to 18 publications in the past year. Additionally, we host 3 graduate student courses, i.e., BMED828, TMED801 and TMED811. QCPU is also home base for 5 Translational MEDicine (TMED) graduate students, 3 Post-docs, 2 QCPU research scientists and 2 Translational Institute of Medicine (TIME) scientists.
QCPU embodies research excellence and will ensure that Queen's research is recognized internationally as a center for translational research. We welcome clincians and researchers who are looking for opportunities to collaborate, whether through our clinic or research center. Please contact QCPU to start your next steps to collaboration!
The team that helped create QCPU through CFI Funding
| Investigator | Department | Specialization |
| Dr. Stephen Archer | Cardiology | Mitochondria Dynamics |
| Dr. Mark Ormiston | Biomedical and Molecular Sciences | NK Cells and Pulmonary Hypertension |
| Dr. Donald Maurice | Biomedical and Molecular Sciences | Cyclic Nucleotide Signaling |
| Dr. Christine D'Arsigny | Respirology | Pulmonary Hypertension |
| Dr. Amer Johri | Cardiology | Cardiac Ultrasound |
| Dr. Paula James | Hematology | Bleeding Disorders |
| Dr. Denis O'Donnell | Respirology | Respiratory mechanics |
| Dr. Diane Lougheed | Respirology / Public Health / ICES | Asthama and cystic fibrosis |
| Dr. Alberto Neder | Respirology | Cardio-circulatory and respiratoty interactions |
| Dr. Sean Taylor | Neurology | Autonomic Profiling |
| Dr. Alastair Ferguson | Neurology | Autonomic control centers |
| Dr. John Fisher | Respirology | Cardiopulmonary genomics |
| Dr. Shetuan Zhang | Biomedical and Molecular Sciences | Ion Channel Dynamics |
| Dr. Evangelos Michelakis | Cardiology - University of Alberta | Pulmonary Hypertension |
| Dr. Thenappan Thenappan | Cardiology - University of Minnesota | Pulmonary Hypertension |
| Dr. Michael Adams | Biomedical and Molecular Sciences | Pathogenesis of vascular diseases |
Dr. Stephen Archer
A CIHR funded cardiologist and physician scientist who is also the Scientific Director of QCPU. His research focus is on defining molecular mechanisms of oxygen sensing, mitochondrial biology and development of mitochondrial metabolic therapies for therapeutics for pulmonary hypertension (PH) and cancer.
Dr. Kimberly Dunham-Snary
An early career research who established the MitoMetaLab. This lab investigates the links between mitochondrial genetics, mitochondrial dynamics, metabolomics, and the cell signalling pathways that control proliferation (cell growth).
Dr. Stephen Vanner
A CIHR funded researcher, and is scientific director of GIDRU, our Digestive Diseases Research Unit. He has an established translational research program that examines mechanisms underlying pain signaling and motility in the gastrointestinal tract, relevant to irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).
Dr. Jacob Rullo
a SEAMO-funded translational. clinician scientist in the Department of Ophthalmology, cross-appointed to the Departments of Biomedical and Molecular Sciences and Medicine. His primary focus is neuro-ophthalmology, which deals with diseases of the eye-brain axis, more specifically his research focus is in characterizing differences in the ocular microenvironment.
Dr. Chris McGlory
A CIHR funded researcher who focuses on trying to understand why people lose muscle during periods of inactivity, such as those experienced by hospital patients when immobile after surgery. Losing muscle in hospital following surgery can trigger diabetes and lead to major negative health outcomes